SLC27A4 antibody
Quick Overview for SLC27A4 antibody (ABIN635777)
Target
See all SLC27A4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purification
- Affinity purified
-
Immunogen
- SLC27 A4 antibody was raised using a synthetic peptide corresponding to a region with amino acids YKFQKTELRKEGFDPAIVKDPLFYLDAQKGRYVPLDQEAYSRIQAGEEKL
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
SLC27A4 Blocking Peptide, (ABIN936114), is also available for use as a blocking control in assays to test for specificity of this SLC27A4 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SLC20 4 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- SLC27A4 (Solute Carrier Family 27 (Fatty Acid Transporter), Member 4 (SLC27A4))
-
Alternative Name
- SLC27A4
-
Background
- SLC27A4 is involved in translocation of long-chain fatty acids (LFCA) across the plasma membrane. It appears to be the principal fatty acid transporter in small intestinal enterocytes. SLC27A4 plays a role in the formation of the epidermal barrier. It is required for fat absorption in early embryogenesis. SLC27A4 has acyl-CoA ligase activity for long-chain and very-long-chain fatty acids.
-
Molecular Weight
- 72 kDa (MW of target protein)
-
Pathways
- Monocarboxylic Acid Catabolic Process
Target
-